Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Hepatitis B vaccine is effective for up to 15 years

Nearly all children who received three doses of hepatitis B vaccine achieved immunity, but about 20% fell below the protective antibody threshold by year 15, Canadian researchers

Published
12 September 2012
By
Liz Highleyman
Viread labeling updates

The Viread label was updated to include dosing information for the treatment of chronic hepatitis B infection in patients 12 years of age and older, and to add 240 week data in adults to the package insert.

Published
30 August 2012
From
EATG
Hepatitis C-The "Diabetes-Curious" and Self Inkers/Piercers at Risk

Viral hepatitis B and C, which can cause life-threatening damage to the liver, can be the unintended consequence of two recent social trends: diabetes curiosity and self-inking/piercing. 'Diabetes curiosity' refers to those who use someone else’s lancet and glucose meter diabetes testing devices to prick themselves to test their own blood sugar levels. Self-inkers/piercers are people who use needles or other devices to create tattoos or pierce themselves or friends. In both cases, a life-threatening hepatitis infection can spread quickly from one person to another. “We have concerns about people borrowing someone else’s diabetes testing equipment to see what their own blood sugar levels are,” said State Epidemiologist Tim Jones, MD. “With these devices now commonplace, the testing process can generate curiosity. Parents need to know and remind children who use the devices not to share them with others, and parents of non-diabetic children should teach everyone in their family to never, ever experiment with another person’s insulin-related equipment.”

Published
22 August 2012
From
HCV New Drugs Research
INDONESIA: Growing concern over hepatitis -

An estimated 25 million Indonesians have either had hepatitis B or C, but only about 20 percent of them know, said Rino Gani, the chairman of the Indonesian Liver Research Association.

Published
17 August 2012
From
IRINnews.org
WHO: Four ways to reduce hepatitis infections in people who inject drugs

WHO has identified four key actions countries can take to prevent viral hepatitis B and C among people who inject drugs. Of the estimated 16 million people who inject drugs worldwide, it is estimated that 10 million are infected with hepatitis C. An additional 1.2 million are infected with hepatitis B.

Published
21 July 2012
From
World Health Organization
Hepatitis B vaccine protects for 25 years: study

Vaccination against hepatitis B seems to protect against the virus for 25 years, suggesting booster shots are unnecessary, according to a new study from Taiwan.

Published
21 June 2012
From
Reuters
NICE consults on new public health guidance aiming to improve uptake of testing for hepatitis B and C

Ignorance about the risk factors and causes of hepatitis B and C, and misconceptions about its treatment need to be tackled if barriers to effective testing of those at increased risk of infection are to be overcome, according to draft guidance issued by NICE.

Published
18 June 2012
From
NICE press release
Hepatitis B is a major health issue for migrants in the US

Between 1.04 million and 1.61 million migrants now resident in the US have chronic hepatitis B infection, investigators report in the online edition of Hepatology.  “The

Published
07 June 2012
By
Michael Carter
Four Bad Actors Cause Most Infection-Related Cancer

Three types of viruses and 1 bacterium cause the vast majority of the new cases of cancer worldwide that are attributable to infections, according to a new study of global data.

Published
11 May 2012
From
Medscape (requires registration)
Brivanib did not improve overall liver cancer survival, but did show anti-tumour activity

The experimental cancer drug brivanib did not lengthen overall survival for patients with hepatocellular carcinoma, but it did increase time to progression, demonstrating that it had anti-tumour

Published
30 April 2012
By
Liz Highleyman

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.